Journal ArticleOPEN ACCESS

Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021

Emerging Infectious Diseases (2023) 29(1) 226-228
DOI: 10.3201/eid2901.221514
2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

During November–December 2021, we performed a SARS-CoV-2 seroprevalence survey in Central and Western Divisions of Fiji. A total of 539 participants 8–70 years of age were 95.5% (95% CI 93.4%–97.1%) seropositive, indicating high community levels of immunity. Seroprevalence studies can inform public health responses to emerging SARS-CoV-2 variants.

Cite

CITATION STYLE

APA

Curtis, S. J., Shah, A. W., Ratu, A., Wilson, D. J., Hill, P. C., Hulcome, P., … Walsh, N. (2023). Rapid SARS-CoV-2 Seroprevalence Survey in Central and Western Divisions of Fiji, 2021. Emerging Infectious Diseases, 29(1), 226–228. https://doi.org/10.3201/eid2901.221514

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free